Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 3, 1999, Pages 267-276

  Woywodt, Alexander ^a,b   Ludwig, Diether ^a   Neustock, Petra ^a   Kruse, Andrea ^a   Schwarting, Karsten ^a   Jantschek, Guenther ^a   Kirchner, Holger ^a   Stange, Eduard F ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Adhesion molecules; Crohn's disease; Cytokines; In situ hybridization; Inflammatory bowel disease; Leucocyte surface markers; Ulcerative colitis

Indexed keywords

CELL ADHESION MOLECULE; CELL MARKER; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; INTESTINE MUCOSA; LAMINA PROPRIA; MACROPHAGE; MALE; PRIORITY JOURNAL; RNA TRANSCRIPTION; ULCERATIVE COLITIS;

EID: 0033031021     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199903000-00010     Document Type: Article

References (35)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991; 325:928-937.
2. MacDermott RP. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Med Clin North Am 1994; 78:1207-1231.
3. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease - enhanced production during active disease. Gut 1990; 31:686-689.
4. Gross, V, Andus T, Caesar I, Roth M, Schölmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992; 102:514-519.
5. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor α in childhood chronic inflammatory bowel disease. Gut 1991; 32:913-917.
6. Hyams JS, Treem WR, Eddy E, Wyzga N, Moore RE. Tumor necrosis factor-α is not elevated in children with inflammatory bowel disease. J Paediatr Gastroenterol Nutr 1991; 12:233-236.
7. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103:1587-1595.
8. Leitch AR, Schwarzacher T, Jackson T, Leitch IJ. In situ hybridization: a practical guide. Oxford: BIOS Scientific; 1994.
9. Rutenfranz I, Kruse A, Rink L, Wenzel B, Arnholdt H, Kirchner H. In situ hybridization of the mRNA for interferon-γ, interferon-α E, interferon-β, interleukin-1β and interleukin-6 and characterization of infiltrating cells in thyroid tissues. J Immunol Methods 1992; 148:233-242.
10. Woywodt A, Neustock P, Kruse A, Schwarting K, Ludwig D, Stange EF, et al. Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1β, interleukin-6 and tumour necrosis factor-α in inflammatory bowel disease. Eur Cytokine Netw 1994; 5:387-395.
11. Springer TA. Traffic signals for leukocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301-314.
12. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. Gastroenterology 1976; 70:439-444.
13. van Hees PAM, van Elteren PH, van Lier HJJ, van Tongeren JHM. An index of inflammatory activity in patients with Crohn's disease. Gut 1980; 21:279-286.
14. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID), presented by Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Gut 1989; 30:983-989.
15. Rachmilewitz D, on behalf of an International Study Group. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 298:82-86.
16. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ 1955; 2:1041-1048.
17. Zilberstein A, Ruggieri R, Korn JH, Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth stimulatory cytokines. EMBO J 1986; 5:2529-2537.
18. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32:219-229.
19. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytchemical evidence of Listeria, Escherichia coli and Streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108:1396-1404.
20. Strober W, Ehrhardt RO. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 1993; 75:203-205.
21. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro T, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995; 154:2434-2440.
22. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989; 30:835-838.
23. Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein J, et al. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 1993; 104:749-758.
24. Cappello M, Keshav S, Prince C, Jewell DP, Gordon S. Detection of the mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 1992; 33:1214-1219.
25. Mitsuyama K, Toyonaga A, Sasaki E, Ishida O, Ikeda H, Tsuruta O, et al. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 1995; 36:45-49.
26. Kindler V, Sappino AP, Grau GE, Piquet PF, Vasalli P. The inducing role of tumor necrosis factor in the development of bactericidal granuloma during BCG infection. Cell 1989; 56:731-740.
27. Targan SR, Hanauer S, van Deventer SJH, Mayer L, Present DH, Braakmann T, et al. Short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Eng J Med 1997; 337:1029-1035.
28. Wilders MM, Sminia T, Plesch BEC, Drexhage HA, Welte-Vreden EF, Meuwissen SGM. Large mononuclear la-positive veiled cells in Peyer's patches. II. Localization in rat Peyer's patches. Immunology 1983; 48:461-467.
29. Allison MC, Cornwall S, Poulter LW, Dhillon AP, Pounder RE. Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut 1988; 29:1531-1538.
30. Bland PW, Kambarage DM. Antigen handling by the epithelium and lamina propria macrophages. Gastroenterol Clin North Am 1991; 20:577-596.
31. Goodman MJ, Skinner JM, Truelove SC. Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet 1976; 1:275-278.
32. Radema SA, van Deventer SJH, Cerami A. Interleukin 1β is expressed predominantly by enterocytes in experimental colitis. Gastroenterology 1991; 100:1180-1186.
33. Jones SC, Trejdosiewicz LK, Banks RE, Howdle PD, Axon ATR, Dixon MF, et al. Expression of interleukin-6 by intestinal enterocytes. J Clin Pathol 1993; 46:1097-1100.
34. Stadnyk AW. Cytokine production by epithelial cells. FASEB J 1994; 8:1041-1047.
35. Malizia G, Calabrese A, Cottone M, Raimondo M, Trejdosiewicz LK, Smart CJ, et al. Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 1991; 100:150-159.